WNT pathway regulators (Kiadis Pharma)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameWNT pathway regulators (Kiadis Pharma)

Drug Alias Namebeta-catenin-Tcf antagonists (Kiadis Pharma)beta-catenin-Tcf antagonists (Hybrigenics)beta-catenin-Tcf antagonists (Semaia)Wnt pathway regulators (Hybrigenics)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCatenin beta 1 degraders

TargetsCatenin beta 1

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsGermanyFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSemaia Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSemaia Pharmaceuticals Hybrigenics SA Kiadis Pharma

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A